惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

Microsoft Azure Blog
Microsoft Azure Blog
aimingoo的专栏
aimingoo的专栏
F
Fortinet All Blogs
Blog — PlanetScale
Blog — PlanetScale
GbyAI
GbyAI
MongoDB | Blog
MongoDB | Blog
月光博客
月光博客
The Cloudflare Blog
量子位
T
Tailwind CSS Blog
Cyber Security Advisories - MS-ISAC
Cyber Security Advisories - MS-ISAC
B
Blog
MyScale Blog
MyScale Blog
T
The Blog of Author Tim Ferriss
The GitHub Blog
The GitHub Blog
G
Google Developers Blog
D
DataBreaches.Net
V
Visual Studio Blog
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
Last Week in AI
Last Week in AI
U
Unit 42
博客园 - 聂微东
有赞技术团队
有赞技术团队
A
About on SuperTechFans

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Astrana Health, Inc. (ASTH) Presents at Bank of America G...
2026-05-13 · via All Articles on Seeking Alpha

Q1: 2026-05-07 Earnings Summary

EPS of $0.74 beats by $0.09

 | 

Revenue of

$965.10M

(55.56% Y/Y)

beats by $16.68M

Astrana Health, Inc. (ASTH) Bank of America Global Healthcare Conference 2026 May 12, 2026 6:40 PM EDT

Company Participants

Brandon Sim - President & CEO

Conference Call Participants

Craig Jones - BofA Securities, Research Division

Presentation

Craig Jones
BofA Securities, Research Division

My name is Craig Jones, I'm of the health care analysts here at Bank of America. And today, I have the pleasure of hosting Brandon Sim, CEO of Astrana Health. So thanks for being here. Do you want to start with an intro or you just want to go straight to Q&A. Yes, go for it.

Brandon Sim
President & CEO

Yes. Well, thanks so much for having us here. It's beautiful to be in my hometown, I guess. So it's nice. Thank you. It's always a great conference every year. And I'm Brandon Sim. I'm the CEO and President here at Astrana Health. We're a value-based care company, trying to realign the system to build infrastructure that allows for better patient outcomes and ultimately, hopefully, at a lower cost. We've been growing very rapidly over the last 6-, 7-year period.

Last year, it grew over 50% year-over-year and continue to grow in a profitable and free cash flowing manner. Some puts and takes, but broadly, we just reported our Q1 results and things came in pretty well ahead of expectations. We grew free cash flow, I think, 3x year-over-year. Revenue grew well over 40%, 50%. So we're pretty pleased with where things are going and look forward to a strong rest of the year here.

Question-and-Answer Session

Craig Jones
BofA Securities, Research Division

Great. All right. So why don't we start with some of your inorganic growth about a year ago or so, closed the acquisition of Prospect. So after the first year, you've guided the high end of the $12 million to $15